• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索拉非尼新辅助治疗用于接受根治性肾切除术的伴有腔静脉延伸的晚期肾细胞癌。

Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy.

作者信息

Di Silverio Franco, Sciarra Alessandro, Parente Ulderico, Andrea Alfarone, Von Heland Magnus, Panebianco Valeria, Passariello Roberto

机构信息

Department of Urology, University of Rome, Rome, Italy.

出版信息

Urol Int. 2008;80(4):451-3. doi: 10.1159/000132708. Epub 2008 Jun 27.

DOI:10.1159/000132708
PMID:18587261
Abstract

A 71-year-old man with advanced left renal cell carcinoma (lymph node involvement and vena cava thrombus) was submitted to 6 months of neoadjuvant treatment with sorafenib before open radical nephrectomy. After sorafenib treatment and before surgery a new CT scan confirmed the presence of a 9.0 cm in diameter solid mass in the left kidney but a reduction in thrombus extension, limited to the left renal vein. At histological examination after radical nephrectomy, over 90% of the renal mass was substituted by necrotic tissue.

摘要

一名71岁的男性患有晚期左肾细胞癌(伴有淋巴结转移和腔静脉血栓形成),在接受开放性根治性肾切除术之前接受了6个月的索拉非尼新辅助治疗。在索拉非尼治疗后且手术前,一次新的CT扫描证实左肾存在一个直径9.0厘米的实性肿块,但血栓延伸范围缩小,仅限于左肾静脉。根治性肾切除术后的组织学检查显示,超过90%的肾脏肿块被坏死组织替代。

相似文献

1
Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy.索拉非尼新辅助治疗用于接受根治性肾切除术的伴有腔静脉延伸的晚期肾细胞癌。
Urol Int. 2008;80(4):451-3. doi: 10.1159/000132708. Epub 2008 Jun 27.
2
Comment on Di Silverio et al.: Neodajuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol Int 2008;80:451-453.
Urol Int. 2008;80(4):454. doi: 10.1159/000136481. Epub 2008 Jun 27.
3
Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.伴有肿瘤血栓延伸至腔静脉的肾细胞癌:前瞻性长期随访
J Urol. 2007 May;177(5):1703-8. doi: 10.1016/j.juro.2007.01.039.
4
Downsizing a thrombus of advanced renal cell carcinoma in a presurgical setting with sorafenib.在术前使用索拉非尼缩小晚期肾细胞癌血栓的体积。
Urol Int. 2012;88(2):235-7. doi: 10.1159/000334484. Epub 2011 Dec 13.
5
[Outcome of surgical management of renal cell carcinoma with renal vein or inferior vena cava tumor thrombus].[肾静脉或下腔静脉瘤栓的肾细胞癌手术治疗结果]
Zhonghua Wai Ke Za Zhi. 2006 May 15;44(10):678-80.
6
Re: renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.关于:累及肾静脉和下腔静脉的肾细胞癌:临床病理特征、手术技术及预后
J Urol. 2005 Nov;174(5):2067; author reply 2067.
7
Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.伴有下腔静脉瘤栓的肾细胞癌肾静脉开口壁侵犯:通过肾静脉和腔静脉直径预测及预后意义
J Urol. 2008 Feb;179(2):450-4; discussion 454. doi: 10.1016/j.juro.2007.09.042.
8
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
9
Renal cell carcinoma invading the inferior vena cava: use of a "temporary" vena cava filter to prevent tumor emboli during nephrectomy.侵犯下腔静脉的肾细胞癌:在肾切除术中使用“临时性”腔静脉滤器预防肿瘤栓子
Urology. 2004 Feb;63(2):380-2. doi: 10.1016/j.urology.2003.10.010.
10
[Renal pelvic cancer with tumor thrombus in the vena cava inferior: a case report].[伴有下腔静脉肿瘤血栓的肾盂癌:一例报告]
Hinyokika Kiyo. 2004 Dec;50(12):869-72.

引用本文的文献

1
Diagnostic accuracy and inter-reader agreement of the nacVI-RADS for bladder cancer treated with neoadjuvant chemotherapy: a prospective validation study.新辅助化疗治疗膀胱癌的nacVI-RADS诊断准确性及阅片者间一致性:一项前瞻性验证研究
Eur Radiol. 2024 Dec 31. doi: 10.1007/s00330-024-11327-w.
2
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.通过生存分析筛选差异基因表达模式,用于透明细胞肾细胞癌的诊断、预后和治疗。
PLoS One. 2024 Sep 30;19(9):e0310843. doi: 10.1371/journal.pone.0310843. eCollection 2024.
3
Surgical management of renal cell carcinoma with subhepatic inferior vena cava tumor thrombus: a case report and review of the literature.
肝下下腔静脉瘤栓肾细胞癌的外科治疗:病例报告及文献复习。
J Med Case Rep. 2024 Apr 23;18(1):201. doi: 10.1186/s13256-024-04517-z.
4
Construction of the prognostic model in non-metastatic renal cancer patients with venous tumor thrombus.非转移性肾细胞癌伴静脉瘤栓患者预后模型的构建。
Transl Androl Urol. 2023 Nov 30;12(11):1645-1657. doi: 10.21037/tau-23-341. Epub 2023 Nov 14.
5
Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation.晚期尿路上皮肿瘤患者身体成分状态的标准化:基于CT的人工智能软件在评估肌肉减少症及患者预后相关性中的作用。
Cancers (Basel). 2023 May 29;15(11):2968. doi: 10.3390/cancers15112968.
6
Performance of Node-RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in Bladder Cancer Patients.用于膀胱癌患者区域淋巴结标准化评估的Node-RADS评分系统的性能
Cancers (Basel). 2023 Jan 18;15(3):580. doi: 10.3390/cancers15030580.
7
Roles of microRNA-186 and vascular endothelial growth factor in hepatocellular carcinoma complicated with portal vein tumor thrombus.微小RNA-186和血管内皮生长因子在肝细胞癌合并门静脉癌栓中的作用
Exp Ther Med. 2020 Oct;20(4):3860-3867. doi: 10.3892/etm.2020.9092. Epub 2020 Aug 3.
8
Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.VEGFA和miR-381在肝细胞癌患者门静脉癌栓中的表达及作用
Exp Ther Med. 2018 Jun;15(6):5450-5456. doi: 10.3892/etm.2018.6129. Epub 2018 May 3.
9
Presurgical neoadjuvant targeted molecular therapy for kidney cancer with concomitant vena cava tumor embolus: A clinical study.伴有腔静脉瘤栓的肾癌术前新辅助靶向分子治疗:一项临床研究
Oncol Lett. 2017 Jul;14(1):369-375. doi: 10.3892/ol.2017.6131. Epub 2017 May 5.
10
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.肾细胞癌治疗的当前临床实践指南:系统评价与批判性评估
Oncologist. 2017 Jun;22(6):667-679. doi: 10.1634/theoncologist.2016-0435. Epub 2017 Jun 7.